Clinical Trial Update: Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares two standard regimens for treating low-risk medulloblastoma, focusing on neurocognitive outcomes. The study status is Not Yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Medulloblastoma | Phase 3 | Status: NOT_YET_RECRUITING